Hedge Fund - Soleus Capital
United Therapeutics Corp (UTHR)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2024 - Q2 (2024-06-30) | $45,074,506 | 3.97% | 141,499 | $264.67 |
2 | 2024 - Q1 (2024-03-31) | $59,669,540 | 4.42% | 259,749 | $225.66 |
3 | 2023 - Q4 (2023-12-31) | $54,851,341 | 6.08% | 249,449 | $230.49 |
4 | 2023 - Q3 (2023-09-30) | $64,861,959 | 5.98% | 287,165 | $230.33 |
5 | 2023 - Q2 (2023-06-30) | $53,583,751 | 5.95% | 242,735 | $221.53 |
6 | 2023 - Q1 (2023-03-31) | $30,511,191 | 3.15% | 136,235 | $246.53 |
7 | 2022 - Q4 (2022-12-31) | $35,670,048 | 5.11% | 128,268 | $252.44 |
8 | 2022 - Q3 (2022-09-30) | $49,175,000 | 6.68% | 234,859 | $223.56 |
9 | 2022 - Q2 (2022-06-30) | $69,641,000 | 10.86% | 295,541 | $203.30 |
10 | 2022 - Q1 (2022-03-31) | $54,873,000 | 7.07% | 305,850 | $190.51 |
11 | 2021 - Q4 (2021-12-31) | $35,502,000 | 3.55% | 164,300 | $196.31 |
12 | 2021 - Q3 (2021-09-30) | $18,790,000 | 2.92% | 101,800 | $196.97 |
The displayed share prices are average quarterly stock market prices.